Cyr61 Decreases Cytarabine Chemosensitivity in Acute Lymphoblastic Leukemia Cells via NF-κB Pathway Activation

International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm.2018.4018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Cyr61 Participates in the Pathogenesis of Acute Lymphoblastic Leukemia by Enhancing Cellular Survival via the AKT/NF-κB Signaling Pathway

Scientific Reports
Multidisciplinary
2016English

Cyr61 Regulates the Chemosensitivity of Chronic Myeloid Leukemia to Imatinib Mesylate Through the NF ‐κB/Bcl‐2 Pathway

Cancer Science
Cancer ResearchMedicineOncology
2019English

Inhibition of MerTK Increases Chemosensitivity and Decreases Oncogenic Potential in T-Cell Acute Lymphoblastic Leukemia

Blood Cancer Journal
OncologyHematology
2013English

Aspirin Inhibits LPS-induced Macrophage Activation via the NF-κB Pathway

Scientific Reports
Multidisciplinary
2017English

Solanine Induced Apoptosis and Increased Chemosensitivity to Adriamycin in T-Cell Acute Lymphoblastic Leukemia Cells

Oncology Letters
Cancer ResearchOncology
2018English

The Notch/Hes1 Pathway Sustains NF-κB Activation Through CYLD Repression in T Cell Leukemia

Cancer Cell
Cancer ResearchOncologyCell Biology
2010English

Inhibition of Notch Signaling Enhances Chemosensitivity in B Cell Precursor Acute Lymphoblastic Leukemia.

Cancer Research
Cancer ResearchOncology
2018English

Activation of Porcine Alveolar Macrophages byActinobacillus Pleuropneumoniaelipopolysaccharide via the TLR4/NF-κB Mediated Pathway

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2017English

Dose Intensification of Daunorubicin and Cytarabine During Treatment of Adult Acute Lymphoblastic Leukemia

Cancer
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy